N-(2-((4-Hydroxyphenyl)Amino)Pyridin-3-Yl)-4-Methoxybenzenesulfonamide N-(2-((4-羟基苯基)氨基)吡啶-3-基)-4-甲氧基苯磺酰胺
CAS 141430-65-1 MFCD00910291
化学结构图
SMILES: COC1C=CC(=CC=1)S(=O)(=O)NC1C=CC=NC=1NC1C=CC(O)=CC=1
化学属性
| Mol. Formula | C18H17N3O4S |
|---|---|
| Mol. Weight | 371.41 |
别名和识别编码
| Chemical Name | N-(2-((4-Hydroxyphenyl)Amino)Pyridin-3-Yl)-4-Methoxybenzenesulfonamide |
|---|---|
| Chemical Name Translation | N-(2-((4-羟基苯基)氨基)吡啶-3-基)-4-甲氧基苯磺酰胺 |
| Reaxys-RN | 5455834 |
| MDL Number | MFCD00910291 |
| PubChem Substance ID | 354335530 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
相关文献及参考
- [2]. Elizabeth Fox et al. A Phase I Study of ABT-751, an Orally Bioavailable Tubulin Inhibitor, Administered Daily for 21 Days Every 28 Days in Pediatric Patients with Solid Tumors Clin Cancer Res February 15, 2008 14; 1111
- [3]. Aggarwal C, Somaiah N, Simon G.,Antiangiogenic agents in the management of non-small cell lung cancer: where do we stand now and where are we headed?,Cancer Biol Ther. 2012 Mar;13(5):247-63.
- [4]. Silver M, Rusk A, Phillips B, Beck E, Jankowski M, Philibert J, Hahn K, Hershey E, McKeegan E, Bauch J, Krivoshik A, Khanna C.,Evaluation of the oral antimitotic agent (ABT-751) in dogs with lymphoma.,J Vet Intern Med. 2012 Mar-Apr;26(2):349-54. doi: 10.1111/j.1939-1676.2012.00892.x. Epub 2012 Feb 28.
- [5]. Gaynon PS, Harned TM; for the Therapeutic Advances in Childhood LeukemiaLymphoma (TACL) Consortium.
- [1]. Huang SM et al.,Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling., Nature. 2009 Oct 1;461(7264):6
